DUBLIN--(BUSINESS WIRE)--The "Global Bloodstream Infection Testing Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.
The global bloodstream infection testing market to grow at a CAGR of 7.11% during the period 2018-2022.
Global Bloodstream Infection Testing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
One trend in the market is increased adoption of automation in healthcare. The healthcare industry is steadily adopting automated solutions to reduce the cost incurred on staffing and to generate accurate results. Also, automated solutions aid healthcare professionals in reducing the time taken for manually intensive tasks.
According to the report, one driver in the market is increasing hospital visits. Hospitals are extremely responsible for spreading infections and increasing the rise in morbidity and mortality in hospitalized patients. The exposure of intensive care units to multiple invasive, therapeutic, and diagnostic procedures, increases the risk of spreading infections.
Further, the report states that one challenge in the market is high cost of instruments. The automated BSI testing products such as blood culture test instruments and equipment are generally expensive. The real-time PCR instruments are more expensive than other instruments.
- F. Hoffmann-La Roche
- Thermo Fisher Scientific
Key Topics Covered:
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Research Methodology
Part 04: Market Landscape
Part 05: Market Sizing
Part 06: Five Forces Analysis
Part 07: Market Segmentation By Technology
Part 08: Customer Landscape
Part 09: Regional Landscape
Part 10: Decision Framework
Part 11: Drivers And Challenges
Part 12: Market Trends
Part 13: Vendor Landscape
Part 14: Vendor Analysis
Part 15: Appendix
For more information about this report visit https://www.researchandmarkets.com/research/446ldq/global?w=4